Minimally invasive therapies for chronic pelvic pain syndrome

Current Urology Reports

Volumn 11, Issue 4, 2010, Pages 276-285

  Wehbe, Salim A ^a   Fariello, Jennifer Y ^a   Whitmore, Kristene ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic pelvic pain syndrome; Chronic prostatitis; Interstitial cystitis; Minimally invasive therapy

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMITRIPTYLINE; ANTIHISTAMINIC AGENT; BOTULINUM TOXIN; CERNITIN; CLONAZEPAM; COTRIMOXAZOLE; CYCLOBENZAPRINE; CYCLOSPORIN; DIMETHYL SULFOXIDE; GABAPENTIN; GLYCOSAMINOGLYCAN; HYDROXYZINE; LIDOCAINE; MONTELUKAST; MUSCLE RELAXANT AGENT; NORTRIPTYLINE; PENTOSAN POLYSULFATE; PLACEBO; POLLENAID; PREDNISONE; PREGABALIN; QUERCETIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESINIFERATOXIN; ROFECOXIB; TAMSULOSIN; TERAZOSIN; TIZANIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; BLADDER IRRIGATION; CHRONIC PROSTATITIS; CLINICAL TRIAL; CYSTALGIA; DIET RESTRICTION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; ELECTROMAGNETIC FIELD; HUMAN; INTERSTITIAL CYSTITIS; MINIMALLY INVASIVE PROCEDURE; NEUROMODULATION; NEUROPATHIC PAIN; PELVIS FLOOR; PELVIS PAIN SYNDROME; PHYSIOTHERAPY; PHYTOTHERAPY; REVIEW; SINGLE DRUG DOSE; TRIGGER POINT; UNSPECIFIED SIDE EFFECT; ELECTROSTIMULATION THERAPY; MALE; PROSTATITIS;

ELECTRIC STIMULATION THERAPY; HUMANS; MALE; MIND-BODY THERAPIES; PHYSICAL THERAPY MODALITIES; PROSTATITIS;

EID: 77956011742     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-010-0120-x     Document Type: Review

References (78)

1. Eisenberg ER, Moldwin RM: Etiology: where does prostatitis stop and interstitial cystitis begin? World J Urol 2003, 21:64-69.
2. Heim LJ: Evaluation and differential diagnosis of dyspareunia. Am Fam Physician 2001, 63:1535-1544.
3. Metts JF: Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician 2001, 64:1199-1206.
4. Nickel JC: Interstitial cystitis-an elusive clinical target? J Urol 2003,170:816-817.
5. Berry SH, Stoto MA, Elliott M, et al.: Prevalence of interstitial cystitis/painful bladder syndrome in the United States. The Rand Interstitial Cystitis Epidemiology (RICE) study. Poster presented at the Annual Meeting of the American Urological Association. Chicago, IL; April 25-30, 2009.
6. Rosenberg MT, Page S, Hazzard MA: Prevalence of interstitial cystitis in a primary care setting. Urology 2007, 69(Suppl 4):48-52.
7. Nickel JC, Downey J, Hunter D, Clark J: Prevalence of prostatitislike symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 2001, 165:842-845.
8. Roberts RO, Jacobson DJ, Girman CJ, et al.: Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol 2002, 168:2467-2471.
9. Forrest JB, Nickel JC, Moldwin RM: Chronic prostatitis/chronic pelvic pain and male interstitial cystitis: Enigmas and opportunities. Urology 2007, 69(Suppl 4):60-63.
10. Nazif O, Teichman J, Gebhart GF: Neural upregulation in interstitial cystitis. Urology 2007, 69(Suppl 4):24-33.
11. Clemens JQ, Markossian T, Calhoun EA: Comparison of economic impact of chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis/painful bladder syndrome. Urology 2009, 73:743-746.
12. Nickel JC, Shoskes D: Phenotypic approach to the management of chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 2009, 10:307-312. This phenotypic approach may represent the most complete therapeutic tool to treat patients with UCPPS.
13. Herati A, Shorter B, Tai J, et al.: Differences in food sensitivities between IC/PBS and CP/CPPS. J Urol 2009, 181(Suppl 4):60.
14. Nickel JC, Baranowski AP, Pontari M, et al.: Management of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome who have failed traditional management. Rev Urol 2007, 9:63-72. This important review outlines innovative treatment strategies for patients with CPPS.
15. Potts JM, O'Dougherty E: Pelvic floor physical therapy for patients with prostatitis. Curr Urol Rep 2000, 1:155-158.
16. Shoskes DA, Berger R, Elmi A, et al.: Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: The chronic prostatitis cohort study. J Urol 2008, 179:556-560.
17. Hetrick DC, Glazer H, Liu YW, et al.: Pelvic floor electromyography in men with chronic pelvic pain syndrome: a case control study. Neurourol Urodyn 2006, 25:46-49.
18. Weiss JM: Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol 2001, 166:2226-2231.
19. Oyama IA, Rejba A, Lukban JC, et al.: Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology 2004, 64:862-865.
20. FitzGerald MP, Anderson RU, Potts J, et al.: Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol 2009, 182:570-580.
21. Ger GC, Wexner SD, Jorge JM, et al.: Evaluation and treatment of chronic intractable rectal pain-a frustrating endeavor. Dis Colon Rectum 1993, 36:139-145.
22. Heah SM, Ho YH, Tan M, Leong AF: Biofeedback is effective treatment for levator ani syndrome. Dis Colon Rectum 1997, 40:187-189.
23. Astin JA: Mind-body therapies for the management of pain. Clin J Pain 2004, 20: 27-32.
24. van Tulder MW, Ostelo R, Vlaeyen JW, et al.: Behavioral treatment for chronic low back pain: a systematic review within the framework of the Cochrane Back Review Group. Spine (Phila PA 1976) 2000, 25:2688-2699
25. Bergeron S, Binik YM, Khalifé S, et al.: A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001, 91:297-306.
26. Mehik A, Hellström P, Sarpola A, et al.: Fears, sexual disturbances and personality features in men with prostatitis: a populationbased cross-sectional study in Finland. BJU Int 2001, 88:35-38.
27. Spinhoven P, Linssen AC: Behavioral treatment of chronic low back pain: Relation of coping strategy use to outcome. Pain 1991, 45:29-34.
28. McCracken LM, Turk LC: Behavioral and Cognitive-Behavioral treatment for chronic pain: Outcome, predictors of outcome and treatment process. Spine (Phila Pa 1976) 2002, 27:2564-2573.
29. Weijenborg PT, Greeven A, Dekker FW, et al.: Clinical course of chronic pelvic pain in women. Pain 2007, 132(Suppl 1):S117-S123.
30. Fall M, Baranowski AP, Elneil S, et al.: EAU Guidelines on chronic pelvic pain. Eur Urol 2010, 57:35-48.
31. Chen R. Nickel JC: Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2003, 61:1156-1159
32. Honjo H, Kamoi K, Naya Y, et al.: Effects of acupuncture for chronic pelvic pain syndrome with intrapelvic venous congestion: preliminary results. Int J Urol 2004, 11:607-612.
33. Lee SW, Liong ML, Yuen KH, et al.: Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. Am J Med 2008, 121:79.e1-e7
34. Lee SH, Lee BC: Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial. Urology 2009, 73:1036-1041.
35. Murphy AB, Macejko A, Taylor A, Nadler RB: Chronic prostatitis: management strategies. Drugs 2009, 69:71-84. This is a very well-structured review of management strategies for CP/CPPS.
36. Nickel J, Zadeikis N, Spivey M: Clinical significance of antimicrobial therapy in chronic prostatitis associated with nontraditional uropathogens. J Urol 2005, 73:S30.
37. Alexander RB, Propert KJ, Schaeffer AJ, et al.: Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004, 141:581-589.
38. Theoharides TC, Sant GR: Immunomodulators for the treatment of interstitial cystitis. Urology 2005, 65:633-638.
39. Soucy F, Grégoire M: Efficacy of prednisone for severe refractory ulcerative interstitial cystitis. J Urol 2005, 173:841-843.
40. Buffington CA: Re: cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol 2006, 176:838.
41. Nickel JC, Pontari M, Moon T, et al.: A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003, 169:1401-1405.
42. Nickel JC, Forrest JB, Tomera K, et al.: Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol 2005, 173:1252-1255.
43. Mishra VC, Browne J, Emberton M: Role of alpha-blockers in type III prostatitis: a systematic review of the literature. J Urol 2007, 177:25-30.
44. Theoharides TC, Sant GR: Hydroxyzine therapy for interstitial cystitis. Urology 1997, 49(Suppl 5A):108-110
45. Bouchelouche K, Nordling J, Hald T, Bouchelouche P: The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis. J Urol 2001, 166:1734-1737.
46. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J: Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999, 54:960-963.
47. Rugendorff EW, Weidner W, Ebeling L, Buck AC: Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol 1993, 71:433-438.
48. Dawson TE, Jamison J: Intravesical treatments for painful bladder syndrome/ interstitial cystitis. Cochrane Database Syst Rev 2007, Issue 4:CD006113.
49. Rössberger J, Fall M, Peeker R: Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome. Scand J Urol Nephrol 2005, 39:73-77.
50. Davis EL, El Khoudary SR, Talbott EO, et al.: Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol 2008, 179:177-185.
51. Payne CK, Mosbaugh PG, Forrest JB, et al.: Intravesical resiniferatoxin for the treatment of interstitial cystitis: A randomized, double-blind, placebo controlled trial. J Urol 2005, 173:1590-1594.
52. Anderson VR, Perry CM: Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis. Drugs 2006, 66:821-835.
53. Nickel JC,Moldwin R, Lee S, et al.: Intravesical alkalinized lidocaine (PSD597) offers sustained relief fromsymptoms of interstitial cystitis and painful bladder syndrome. BJU Int 2009, 103:910-918.
54. Theoharides TC, Whitmore K, Stanford E, et al.: Interstitial cystitis: bladder pain & beyond. Expert Opin Pharmacother 2008, 9:2979-2994.
55. Evans RJ: Treatment approaches for interstitial cystitis: multimodal therapy. Rev Urol 2002, 4(Suppl 1):S16-S20.
56. Kang YS, Jeong SY, Cho HJ, et al.: Transanally injected triamcinolone acetonide in levator syndrome. Dis Colon Rectum 2000, 43:1288-1291.
57. Langford CF, Udvari Nagy S, Ghoniem GM: Levator ani trigger point injections: An underutilized treatment for chronic pelvic pain. Neurourol Urodyn 2007, 26:59-62.
58. Abbott JA, Jarvis SK, Lyons SD, et al.: Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol 2006, 108:915-923.
59. Rao SS, Paulson J, Mata M, Zimmerman B: Clinical trial: effects of botulinum toxin on levator ani syndrome-a double-blind, placebocontrolled study. Aliment Pharmacol Ther 2009, 29:985-991.
60. Chuang YC, Chancellor MB: The application of botulinum toxin in the prostate. J Urol 2006, 176(6 Pt 1):2375-2382.
61. Moldwin RM, Evans RJ, Stanford EJ, Rosenberg MT: Rational approaches to the treatment of patients with interstitial cystitis. Urology 2007, 69(Suppl 4):73-81.
62. Peters KM, Carey JM, Konstandt, DB: Sacral neuromodulation for the treatment of interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct 2003, 14:223-228.
63. Brookoff DM, Bennett DS: Neuromodulation in intractable interstitial cystitis and related pelvic pain syndromes. Pain Med 2006, 7(S1):166-184
64. Everaert K, Devulder J, De Muynck M, et al.: The pain cycle: implications for the diagnosis and treatment of pelvic pain syndromes. Int Urogynecol J Pelvic Floor Dysfunct 2001, 12:9-14.
65. Siegel S, Paszkiewicz E, Kirkpatrick C, et al.: Sacral nerve stimulation in patients with chronic intractable pelvic pain. J Urol 2001, 166:1742-1745.
66. Maher CF, Carey MP, Dwyer PL, Schluter PL: Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J Urol 2001, 165:884-886.
67. Comiter CV: Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol 2003, 169:1369-1373.
68. Peters KM, Konstandt D: Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int 2004, 93:777-779.
69. Whitmore KE, Payne CK, Diokno AC, Lukban JC: Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J Pelvic Floor Dysfunct 2003,14:305-308.
70. Hellstrom WJ, Schmidt RA, Lue TF, Tanagho EA: Neuromuscular dysfunction in nonbacterial prostatitis. Urology 1987, 30:183-188.
71. Mayer RD, Howard FM: Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain. Neurotherapeutics 2008, 5:107-113.
72. Congregado Ruiz B, Pena Outeiriño XM, Campoy Martínez P, et al.: Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol 2004, 45:65-69.
73. Groen J, Amiel C, Bosch JL: Chronic pudendal nerve neuromodulation in women with idiopathic refractory detrusor overactivity incontinence: results of a pilot study with a novel minimally invasive implantable mini-stimulator. Neurourol Urodyn 2005, 24:226-230.
74. Peters KM, Feber KM, Bennett RC: Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial. Neurourol Urodyn 2005, 24:643-647.
75. Peters KM, Killinger KA, Boguslawski BM, Boura JA: Chronic pudendal neuromodulation: Expanding available treatment options for refractory urologic symptoms. Neurourol Urodyn 2009 Sep 28 (Epub ahead of print).
76. Carmel M, Lebel M, Tu LM: Pudendal nerve neuromodulation with neurophysiology guidance: a potential treatment option for refractory chronic pelvi-perineal pain. Int Urogynecol J Pelvic Floor Dysfunct 2010, 21:613-616.
77. Rowe E, Smith C, Laverick L, et al.: A prospective, randomized, placebo controlled, double-blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. J Urol 2005, 173:2044-2047.
78. Paick JS, Lee SC, Ku JH: More effects of extracorporeal magnetic innervations and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study. Prostate Cancer Prostatic Dis 2006, 9:261-265.